Trial Outcomes & Findings for Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day (NCT NCT04547582)
NCT ID: NCT04547582
Last Updated: 2026-01-07
Results Overview
Investigators will track the number of participants experiencing serious device-related adverse events, such as unresolved superficial infection resulting in lead removal, deep infection, inpatient hospitalization, withdrawal from the study due to worsening pain or intolerable dysesthesia, or fracture due to falls related to the study interventions, that occur during the course of and up to 90 days following implantation.
TERMINATED
NA
4 participants
90 days
2026-01-07
Participant Flow
Subjects were enrolled from 2021 to 2023 from affiliated amputee clinics. Recruitment continued through 2025, but no additional subjects were enrolled.
Enrollment is defined as completing informed consent.
Participant milestones
| Measure |
Spinal Cord Stimulation
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Overall Study
STARTED
|
1
|
|
Overall Study
COMPLETED
|
1
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day
Baseline characteristics by cohort
| Measure |
Spinal Cord Stimulation
n=1 Participants
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation. Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders. Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=37 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
1 Participants
n=37 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=37 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=37 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=37 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=37 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=37 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=37 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=37 Participants
|
|
Race (NIH/OMB)
White
|
1 Participants
n=37 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=37 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=37 Participants
|
|
Region of Enrollment
United States
|
1 participants
n=37 Participants
|
PRIMARY outcome
Timeframe: 90 daysPopulation: One participant was implanted with spinal cord stimulation leads.
Investigators will track the number of participants experiencing serious device-related adverse events, such as unresolved superficial infection resulting in lead removal, deep infection, inpatient hospitalization, withdrawal from the study due to worsening pain or intolerable dysesthesia, or fracture due to falls related to the study interventions, that occur during the course of and up to 90 days following implantation.
Outcome measures
| Measure |
Spinal cord stimulation
n=1 Participants
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Number of Participants Experiencing Serious Device-related Adverse Events up to 90 Days Following Implantation
|
0 Participants
|
PRIMARY outcome
Timeframe: 90 daysQuantify the threshold stimulus required to evoke sensory percepts during epidural spinal nerve stimulation.
Outcome measures
| Measure |
Spinal cord stimulation
n=1 Participants
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Minimum Amplitude of Pulse Required to Evoke Sensory Percepts
|
2 milliamps
|
PRIMARY outcome
Timeframe: 90 daysQuantify the threshold (minimum charge) stimulus required to evoke neurophysiological responses during epidural spinal nerve stimulation
Outcome measures
| Measure |
Spinal cord stimulation
n=1 Participants
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Minimum Charge Required to Evoke a Neurophysiological Response
|
1.23 uC (microcoulombs)
|
PRIMARY outcome
Timeframe: 90 daysParticipants reporting sensation on missing toes from spinal cord stimulation.
Outcome measures
| Measure |
Spinal cord stimulation
n=1 Participants
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Location of Evoked Sensation - Missing Toes
|
1 Participants
|
PRIMARY outcome
Timeframe: 90 daysParticipants perceiving sensation on the plantar surface of missing foot
Outcome measures
| Measure |
Spinal cord stimulation
n=1 Participants
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Location of Evoked Sensation - Plantar Surface of Missing Foot
|
1 Participants
|
SECONDARY outcome
Timeframe: Pre-implant (baseline), Weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and post-explant (90 days)The McGill Pain Questionnaire is a questionnaire used to evaluate the severity of pain experienced by the participant. The questionnaire is scaled, with a minimum and maximum pain score of 0 and 78, respectively. The higher the score on the questionnaire, the more intense the pain felt by the participant. A lower score than previously reported represents a decrease in experienced phantom limb pain. Before placement of the spinal cord stimulator leads, investigators will document the subject's description of their history of perceived phantom limb. Investigators will ask them to periodically update their perception of the limb throughout experimental sessions, as well as within a month after the device has been removed.
Outcome measures
| Measure |
Spinal cord stimulation
n=1 Participants
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Pre-implant (baseline)
|
48 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 1 (after implant)
|
32 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 2
|
45 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 3
|
45 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 4
|
23 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 5
|
38 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 6
|
32 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 7
|
34 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 8
|
17 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 9
|
46 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 10
|
41 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Week 11
|
65 score on a scale
|
|
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
Post-explant (90 days)
|
47 score on a scale
|
SECONDARY outcome
Timeframe: 90 daysPopulation: For all reported sensations, each electrode was stimulated with a 1-second long pulse train.
Document the subjective perception of lumbosacral epidural spinal nerve stimulation for restoration of sensation. The investigators will ask each subject to provide subjective feedback on their perceived utility of the sensory feedback provided by the device. A total of 13 natural descriptors and 5 paresthetic descriptors were presented to participants weekly to describe the sensation provided via spinal cord stimulation. The goal of the study is to elicit more natural than paresthetic descriptors from participants. Natural: pressure, tickle, flutter, warm, sharp, prick, cool, pulsing, vibration, itch, urge to move, touch, tap Parethetic: buzz, tingle, shock, electric current, numb
Outcome measures
| Measure |
Spinal cord stimulation
n=1 Participants
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Qualitative Self-report of Evoked Sensations
More natural than paresthetic descriptors.
|
1 Participants
|
|
Qualitative Self-report of Evoked Sensations
More paresthetic than natural descriptors.
|
0 Participants
|
SECONDARY outcome
Timeframe: 90 daysPopulation: Individuals implanted with spinal cord stimulator leads in lumbar spine
Investigators will test the subject's success rate during control of prosthetic limb with and without sensory feedback provided by electrical stimulation of the spinal roots. Using either a virtual prosthetic limb or an instrumented prosthesis, stimulation of the spinal roots will be modulated based on signals recorded from the limb.
Outcome measures
| Measure |
Spinal cord stimulation
n=1 Participants
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Able to Use a Prosthetic Limb With Neural Signals
|
1 Participants
|
Adverse Events
Spinal Cord Stimulation
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Spinal Cord Stimulation
n=1 participants at risk
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.
Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
|
|---|---|
|
Surgical and medical procedures
Incision pain
|
100.0%
1/1 • Number of events 1 • 90 days
Self-report by participant
|
|
Surgical and medical procedures
Chest pain after surgery
|
100.0%
1/1 • Number of events 1 • 90 days
Self-report by participant
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place